uniQure (QURE) Tax Provisions (2016 - 2026)
uniQure (QURE) recorded quarterly Tax Provisions of $488000.0 in Q1 2026, up 113.84% quarter-over-quarter from -$3.5 million in Q4 2025, and down 1.61% on a YoY basis from $496000.0 in Q1 2025.
uniQure (QURE) Tax Provisions (2016 - 2026) Analysis & Trends
uniQure's Tax Provisions history runs 10 years deep, the most recent figure standing at $488000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 1.61% year-over-year to $488000.0; the TTM figure through Mar 2026 stood at $4.9 million (up 33.32% YoY), while the FY2025 annual figure was $4.0 million, up 66.45% from the prior year.
- Tax Provisions was $488000.0 for Q1 2026 at uniQure, up from -$3.5 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $7.5 million in Q3 2025 to a low of -$3.5 million in Q4 2025.
- Historically, Tax Provisions has averaged $570470.6 across 5 years, with a median of $163000.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions slumped 469.66% in 2022, then jumped 24361.29% in 2025.
- A 5-year view of Tax Provisions shows it stood at -$207000.0 in 2022, then surged by 1565.7% to $3.0 million in 2023, then declined by 25.21% to $2.3 million in 2024, then slumped by 255.35% to -$3.5 million in 2025, then jumped by 113.84% to $488000.0 in 2026.
- The last three Tax Provisions figures came in at $488000.0 (Q1 2026), -$3.5 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 488,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 488,000.00 |
| Dec 31, 2025 | -3.53 Mn |
| Sep 30, 2025 | 7.52 Mn |
| Jun 30, 2025 | 425,000.00 |
| Mar 31, 2025 | 496,000.00 |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | -31,000.00 |
| Jun 30, 2024 | 948,000.00 |
| Mar 31, 2024 | 656,000.00 |
| Dec 31, 2023 | 3.03 Mn |
| Sep 30, 2023 | -69,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | -1.21 Mn |
| Dec 31, 2022 | -207,000.00 |
| Sep 30, 2022 | -329,000.00 |
| Jun 30, 2022 | -318,000.00 |
| Mar 31, 2022 | -616,000.00 |
| Dec 31, 2021 | -3.55 Mn |
| Sep 30, 2021 | 89,000.00 |
| Jun 30, 2021 | 3.26 Mn |